Plastic surgery

TissuGlu Approved for New Trials

Cohera Medical has received approval from the United States Food and Drug Administration to begin the first no-drain clinical trial for its TissuGlu Surgical Adhesive product in the U.S. The randomized, controlled, prospective multicenter non-inferiority study will compare the standard wound closure technique with drains (control) to the standard wound closure technique including TissuGlu and no drains (test) during abdominoplasty procedures.